Glycopyrrolate + Indacaterol Generics - Manufacturers & Suppliers
Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)
| Product/Composition:- | Glycopyrrolate + Indacaterol |
|---|---|
| Strength:- | Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg |
| Form:- | Inhalation powder delivered via Neohaler device/Breezhaler device |
| Reference Brands:- | Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Glycopyrrolate + Indacaterol is a dual bronchodilator used for long-term COPD management. It combines a LAMA and LABA to improve breathing and reduce symptoms. Sold as Ultibro Breezhaler in the EU, it offers once-daily relief and better lung function, but is not for acute symptom relief.
Glycopyrrolate + Indacaterol is a dual bronchodilator combination used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA), while Indacaterol is a long-acting beta2-agonist (LABA). Together, they provide effective, once-daily bronchodilation, improving lung function and reducing COPD symptoms like breathlessness. Marketed under brand names such as Ultibro Breezhaler in the EU and previously as Utibron Neohaler in the US, this inhalation therapy offers enhanced respiratory relief. It is not intended for acute symptom relief but plays a vital role in COPD management by optimizing airflow and improving patients’ quality of life.